Page 3 - Commodore Capital News Today

Commodore Capital LP boosted its holdings in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 112.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,675,000 shares of the company’s stock after acquiring an additional 885,000 shares during the quarter. Akero Therapeutics accounts […]

Commodore Capital LP boosted its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 6.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 610,000 shares of the biotechnology company’s stock after buying an additional 35,000 shares during the period. Arrowhead Pharmaceuticals accounts […]

Commodore Capital LP grew its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 6.1% during the second quarter, Holdings Channel.com reports. The fund owned 610,000 shares of the biotechnology company’s stock after purchasing an additional 35,000 shares during the quarter. Arrowhead Pharmaceuticals makes up 2.4% of Commodore Capital LP’s investment portfolio, making the […]

Commodore Capital LP boosted its position in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) by 35.6% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 2,348,272 shares of the company’s stock after acquiring an additional 616,907 shares during the quarter. Enliven Therapeutics comprises […]

Commodore Capital LP purchased a new position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 775,000 shares of the company’s stock, valued at approximately $18,212,000. IDEAYA Biosciences comprises approximately […]

Commodore Capital LP increased its position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 112.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,675,000 shares of the company’s stock after purchasing an additional 885,000 shares during the quarter. Akero Therapeutics comprises approximately 8.8% of Commodore Capital LP’s portfolio, making the stock […]

Commodore Capital LP lifted its holdings in shares of Celcuity Inc. (NASDAQ:CELC – Free Report) by 3.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,444,141 shares of the company’s stock after buying an additional 53,369 shares during the period. […]

Commodore Capital LP boosted its position in shares of Merus (NASDAQ:MRUS – Free Report) by 35.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,000,000 shares of the biotechnology company’s stock after acquiring an additional 1,050,000 shares during the period. Merus comprises 11.8% […]

Commodore Capital LP acquired a new stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 775,000 shares of the company’s stock, valued at approximately $18,212,000. IDEAYA Biosciences accounts for about 2.0% […]

Commodore Capital LP grew its holdings in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 100.0% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,000,000 shares of the biotechnology company’s stock after purchasing an additional 5,000,000 shares during the quarter. Adverum […]